Who owns Nektar Therapeutics?

Key details on Nektar Therapeutics (Ticker: NKTR)

Who owns Nektar Therapeutics?

Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.

Fund Name Number of Shares Share Valuation As Of
OppenheimerFunds 24.40M $294.51M Sept. 30, 2014
PRIMECAP Management Company 18.14M $218.92M Sept. 30, 2014
HealthCor Management 9.20M $66.88M June 30, 2011
Vanguard 8.12M $98.01M Sept. 30, 2014
First Trust Advisors 6.14M $74.06M Sept. 30, 2014
Federated Investors 5.87M $70.87M Sept. 30, 2014
Ulys 5.17M $28.93M Dec. 31, 2011
JPMORGAN CHASE & CO 4.43M $53.45M Sept. 30, 2014
BlackRock Fund Advisors 4.31M $51.97M Sept. 30, 2014
STATE STREET CORPORATION 4.16M $50.25M Sept. 30, 2014
HealthCor Management 4.00M $46.20M June 30, 2013
BlackRock Institutional Trust Company, N.A. 3.45M $41.68M Sept. 30, 2014
GRANAHAN INVESTMENT MANAGEMENT INC/MA 3.44M $41.56M Sept. 30, 2014
Franklin Resources 3.04M $38.93M June 30, 2014
Deerfield Management Company 2.94M $33.95M June 30, 2013
Invus Public Equities Advisors 2.75M $19.99M June 30, 2011
BVF 2.73M $20.26M Dec. 31, 2012
Barclays 2.71M $21.48M March 31, 2012
Tang Capital Management 2.20M $23.50M Sept. 30, 2012
Artal Group S.A. 2.15M $27.56M June 30, 2014

Who sold Nektar Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2010 3.49M $44.80M
Tudor Investment Corporation Sept. 30, 2005 1.98M $33.57M
Maverick Capital Dec. 31, 2004 2.47M $50.04M